Sugi Predict

Sugi Predict / Compounds / SCHEMBL194067

SCHEMBL194067

SCHEMBL194067

CCCCN1CC(=O)NC1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 1/20 0.46
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ CYP4F2 P78329 1/20 0.38
▸ CYP4A11 Q02928 1/20 0.38
▸ ALOX5 P09917 2/20 0.36
▸ GAA P10253 3/20 0.35
▸ TP53 P04637 1/20 0.35
▸ ALDH1A1 P00352 5/20 0.35
▸ HPGD P15428 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ TDP1 Q9NUW8 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL461664 0.94 CRBN (0.45) CRBNMEN1KMT2ACYP4F2CYP4A11
SCHEMBL20376257 0.92 ALOX5 (0.45) CRBNCYP4F2CYP4A11ALOX5ALDH1A1
SCHEMBL8716131 0.92 ALOX5 (0.45) CRBNCYP4F2CYP4A11ALOX5ALDH1A1
SCHEMBL3628533 0.92 ALOX5 (0.45) CRBNCYP4F2CYP4A11ALOX5ALDH1A1
SCHEMBL162839 0.92 ALOX5 (0.45) CRBNCYP4F2CYP4A11ALOX5ALDH1A1
SCHEMBL6228568 0.92 ALOX5 (0.45) CRBNCYP4F2CYP4A11ALOX5ALDH1A1
SCHEMBL6233785 0.92 ALOX5 (0.45) CRBNCYP4F2CYP4A11ALOX5ALDH1A1
SCHEMBL6233217 0.92 ALOX5 (0.45) CRBNCYP4F2CYP4A11ALOX5ALDH1A1
SCHEMBL20441211 0.92 ALOX5 (0.45) CRBNCYP4F2CYP4A11ALOX5ALDH1A1
SCHEMBL193400 0.87 CRBN (0.50) CRBNMEN1KMT2ACYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118374903-B Cool inductor-based polyester fiber fabric, preparation method and application thereof in underwear 汕头市至上科技有限公司 2024-08-20 — — CN claimed
CN-115449861-A Manufacturing method of flexible titanium metal part capable of being rolled 东莞奕创表面处理科技有限公司 2022-12-09 — — CN claimed
US-5707837-A Method of producing (R)-tertiary leucine DEGUSSA AKTIENGESELLSCHAFT (DE) 1998-01-13 — — US claimed
EP-0471591-B1 Process for absorption of sulfur compounds from fluids using heterocyclic compounds having at least one ring nitrogen atom DOW CHEMICAL CO (US) 1995-05-10 — — EP claimed
US-5342593-A Contacting with a hydantoin, triazinone, 2,4-pyrimidinedione or oxazolidone; can be regenerated THE DOW CHEMICAL COMPANY (US) 1994-08-30 — — US claimed
EP-0552360-A1 A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE THE DOW CHEMICAL COMPANY (US) 1993-07-28 — — EP claimed
WO-1993003825-A1 A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE THE DOW CHEMICAL COMPANY (US) 1993-03-04 — — WO claimed
US-5167941-A Sulfur dioxide; cationic polyelectrolyte stabilizers THE DOW CHEMICAL COMPANY (US) 1992-12-01 — — US claimed
EP-0471591-A2 Process for absorption of sulfur compounds from fluids using heterocyclic compounds having at least one ring nitrogen atom THE DOW CHEMICAL COMPANY (US) 1992-02-19 — — EP claimed
US-3937755-A POLYESTERS HAVING IMPROVED DISPERSE DYEABILITY THE GOODYEAR TIRE & RUBBER COMPANY (US) 1976-02-10 — — US claimed
JP-10072446-A — — None — — JP disclosed
JP-7222593-A — — None — — JP disclosed
EP-3601291-B1 11,13-MODIFIED SAXITOXINS FOR THE TREATMENT OF PAIN SITEONE THERAPEUTICS INC (US) 2026-05-20 — — EP disclosed
US-20250228865-A1 COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME SANOFI US SERVICES INC. (US) 2025-07-17 — — US disclosed
US-20250120400-A1 SYNTHESIS OF GLUFOSINATE USING A HYDANTOINASE-BASED PROCESS BASF SE (DE) 2025-04-17 — — US disclosed
WO-1993013077-A1 ANGIOTENSIN II RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1993-07-08 — — WO disclosed
WO-1993003825-A1 A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE THE DOW CHEMICAL COMPANY (US) 1993-03-04 — — WO disclosed
US-5167941-A Sulfur dioxide; cationic polyelectrolyte stabilizers THE DOW CHEMICAL COMPANY (US) 1992-12-01 — — US disclosed
EP-0471591-A2 Process for absorption of sulfur compounds from fluids using heterocyclic compounds having at least one ring nitrogen atom THE DOW CHEMICAL COMPANY (US) 1992-02-19 — — EP disclosed
US-4436910-A SAPONIFICATION DEGUSSA AKTIENGESELLSCHAFT (DE) 1984-03-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250228865-A1 COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME UPF1, NUDT21, RNGTT CRBN 1442/4885MEN1 4458/4885KMT2A 1656/4885
US-20250120400-A1 SYNTHESIS OF GLUFOSINATE USING A HYDANTOINASE-BASED PROCESS GLUL, ASNS, DNPEP CRBN 2217/4885MEN1 1853/4885KMT2A 512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.